Are anti-EGFR monoclonal antibodies the magic bullets that remove circulating tumor cells in patients with non-small cell lung cancer (NSCLC)?
- Marjolein van Egmond (Recipient)
- Molecular cell biology and Immunology
- Surgery
- Amsterdam Gastroenterology Endocrinology Metabolism - Digestive Immunity
- Amsterdam Gastroenterology Endocrinology Metabolism - Re-generation and Cancer of the Digestive System
- Cancer Center Amsterdam - Cancer Biology and Immunology
- Cancer Center Amsterdam - Imaging and Biomarkers
- Cancer Center Amsterdam - Treatment and Quality of Life
- Amsterdam Infection and Immunity - Inflammatory Diseases
Prize